Medicare Enrolled
Dr. Mohammad Ismail, MD
Optician · Carlisle, PA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ismail from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ismail?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ismail
Dr. Mohammad Ismail is an optician specialist in Carlisle, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Ismail performed 12,123 Medicare services across 1,372 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ismail received a total of $12,666 from 78 pharmaceutical and/or device companies across 672 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ismail is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 2% volume in PA
$12,666 industry payments
Medicare Practice Summary
Medicare Utilization ↗12,123
Medicare services
Top 2% in PA for optician
1,372
Unique beneficiaries
$19
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~606 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
10,301 | $5 | $8 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
529 | $93 | $135 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
185 | $96 | $215 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
141 | $133 | $304 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
138 | $73 | $160 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
122 | $92 | $182 |
| Injection, methylprednisolone acetate, 40 mg | 76 | $6 | $30 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
70 | $126 | $210 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
69 | $159 | $425 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
50 | $316 | $540 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
48 | $161 | $420 |
| EEG monitoring, 2-12 hours with review This procedure records brain wave activity for 2 to 12 hours. A healthcare professional reviews the data and provides a report. |
47 | $75 | $150 |
| Psychological test administration, each additional 30 minutes A technician administers psychological or neuropsychological testing. This code covers each additional 30-minute increment of administration time. |
39 | $21 | $65 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
39 | $58 | $126 |
| Neuropsychological test evaluation, first hour A professional assessment of cognitive and behavioral functioning using standardized tests. This service covers the initial hour of the evaluation process. |
37 | $88 | $150 |
| Psychological test administration, first 30 minutes A technician administers psychological or neuropsychological testing for the first 30 minutes. |
37 | $22 | $65 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
31 | $284 | $540 |
| Injection of anesthetic or steroid into upper neck and back of head nerve An injection of an anesthetic agent and/or steroid into a nerve located in the upper neck and back of the head. |
27 | $83 | $283 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
24 | $62 | $100 |
| Trigger point injection, 1-2 muscles A procedure involving the injection of medication into one or two specific muscles to treat trigger points. |
22 | $38 | $75 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
22 | $129 | $350 |
| Chemical nerve block injection, 5+ arm/leg muscles Injection of a chemical agent to paralyze five or more muscles in the first extremity treated. |
19 | $134 | $195 |
| Lumbar puncture for diagnostic test A procedure to remove cerebrospinal fluid from the lower back for diagnostic testing. |
18 | $89 | $255 |
| Chemical nerve paralysis injection, each additional extremity Injection of a chemical agent to paralyze nerves and muscles in an additional arm or leg. This is billed for each extremity beyond the first one treated. |
18 | $91 | $138 |
| EEG monitoring, 12-26 hours with review This procedure involves monitoring brain wave activity for 12 to 26 hours. A healthcare professional reviews the data and provides a report. |
14 | $107 | $200 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$12,666
Total received (2018-2024)
Avg $1,809/year across 7 years
Top 14% in PA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
78
Companies
672
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,432 (98.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$233 (1.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,175
2023
$2,749
2022
$2,197
2021
$1,886
2020
$1,127
2019
$1,082
2018
$1,450
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$210
Celgene Corporation
$167
Amneal Pharmaceuticals LLC
$146
Alexion Pharmaceuticals, Inc.
$129
ARGENX US, INC.
$115
Lundbeck LLC
$105
Genentech USA, Inc.
$102
Lilly USA, LLC
$100
AstraZeneca Pharmaceuticals LP
$92
EMD Serono, Inc.
$84
Biogen, Inc.
$74
Axsome Therapeutics, Inc.
$73
CATALYST PHARMACEUTICALS, INC.
$64
Neurocrine Biosciences, Inc.
$64
PFIZER INC.
$64
Neurelis, Inc.
$62
MDD US Operations, LLC
$61
Otsuka America Pharmaceutical, Inc.
$58
Takeda Pharmaceuticals U.S.A., Inc.
$42
TG Therapeutics, Inc.
$42
Eisai Inc.
$36
Amgen Inc.
$36
HARMONY BIOSCIENCES LLC
$36
ACADIA Pharmaceuticals Inc
$33
Novartis Pharmaceuticals Corporation
$27
Kyowa Kirin, Inc.
$26
MITSUBISHI TANABE PHARMA AMERICA, INC.
$22
Vanda Pharmaceuticals Inc.
$21
JAZZ PHARMACEUTICALS INC.
$20
IDORSIA PHARMACEUTICALS US INC
$19
W. L. Gore & Associates, Inc.
$17
CSL Behring
$17
Sumitomo Pharma America, Inc.
$13
Top 3 companies account for 24.1% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$891
Celgene Corporation
$815
Teva Pharmaceuticals USA, Inc.
$793
Supernus Pharmaceuticals, Inc.
$787
Biogen, Inc.
$757
MicroVention, Inc.
$704
EMD Serono, Inc.
$591
Alexion Pharmaceuticals, Inc.
$352
Lilly USA, LLC
$343
ACADIA Pharmaceuticals Inc
$307
Amneal Pharmaceuticals LLC
$269
Novartis Pharmaceuticals Corporation
$258
GENZYME CORPORATION
$236
Neurocrine Biosciences, Inc.
$232
Lundbeck LLC
$217
AstraZeneca Pharmaceuticals LP
$216
PFIZER INC.
$201
JAZZ PHARMACEUTICALS INC.
$199
Genentech USA, Inc.
$193
NOVARTIS PHARMACEUTICALS CORPORATION
$192
Neurelis, Inc.
$175
Eisai Inc.
$165
C. R. Bard, Inc. & Subsidiaries
$160
ARGENX US, INC.
$157
Biohaven Pharmaceutical Holding Company Ltd.
$150
MDD US Operations, LLC
$146
Takeda Pharmaceuticals U.S.A., Inc.
$143
SK Life Science, Inc.
$137
Allergan, Inc.
$133
AbbVie Inc.
$132
UCB, Inc.
$132
Otsuka America Pharmaceutical, Inc.
$117
EISAI INC.
$117
CSL Behring
$117
Ipsen Biopharmaceuticals, Inc
$112
Kyowa Kirin, Inc.
$112
Amgen Inc.
$111
CATALYST PHARMACEUTICALS, INC.
$103
US WorldMeds, LLC
$92
Biohaven Pharmaceuticals, Inc.
$90
E.R. Squibb & Sons, L.L.C.
$88
Axsome Therapeutics, Inc.
$73
Adamas Pharmaceuticals, Inc.
$72
Jazz Pharmaceuticals Inc.
$71
Avanir Pharmaceuticals, Inc.
$69
Acorda Therapeutics, Inc
$68
HARMONY BIOSCIENCES LLC
$66
Janssen Pharmaceuticals, Inc
$65
Sumitomo Pharma America, Inc.
$64
Medtronic, Inc.
$61
Scilex Pharmaceuticals Inc.
$58
Greenwich Biosciences, Inc.
$50
MITSUBISHI TANABE PHARMA AMERICA, INC.
$50
Harmony Biosciences LLC
$50
UPSHER-SMITH LABORATORIES LLC
$48
Electronic Waveform Lab, Inc.
$46
TG Therapeutics, Inc.
$42
Mallinckrodt Enterprises LLC
$39
Mallinckrodt LLC
$34
Almatica Pharma LLC
$33
Mallinckrodt Hospital Products Inc.
$31
Impax Laboratories, Inc.
$29
Catalyst Pharmaceuticals, Inc.
$29
ASSERTIO THERAPEUTICS, Inc.
$25
Avion Pharmaceuticals
$24
Novo Nordisk Inc
$24
Upsher-Smith Laboratories LLC
$22
Vanda Pharmaceuticals Inc.
$21
LivaNova USA, Inc.
$21
IDORSIA PHARMACEUTICALS US INC
$19
Ironshore Pharmaceuticals Inc.
$18
W. L. Gore & Associates, Inc.
$17
TG THERAPEUTICS, INC.
$15
ARBOR PHARMACEUTICALS, INC.
$14
Mitsubishi Tanabe Pharma America, Inc.
$14
Grifols USA, LLC
$14
Bayer HealthCare Pharmaceuticals Inc.
$14
Assertio Therapeutics, Inc.
$12
Top 3 companies account for 19.7% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · AXIUM PRIMETM · Aimovig · Apokyn · BOTOX · BRIUMVI · Betaseron · Briviact · COPAXONE · CREXONT · Cambia · DYSPORT · Dhivy · Dysport · EMGALITY · EPIDIOLEX · Enspryng · Epidiolex · FARXIGA · FIRDAPSE · FYCOMPA · Fycompa · GILENYA · GOCOVRI · GRALISE · Gamunex-C · Gocovri · Gralise · HYQVIA · Hizentra · Horizant · INBRIJA · INGREZZA · Jornay PM 20mg capsules (Bottle of 100) · KESIMPTA · KISUNLA · LOKELMA · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MYOBLOC · Mavenclad · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · Nourianz · OCREVUS · ONGENTYS · ONGENTYS 50MG CAPSULES 30 · OXTELLAR XR · Ocrevus · PANZYGA · PLEGRIDY · POMPE - DISEASE · PONVORY · QULIPTA · QUVIVIQ · RADICAVA · REXULTI · RYTARY · Radicava · SOLIRIS · SPINRAZA · SUNOSI · Soliris · Sunosi · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TRINTELLIX · TROKENDI XR · TYSABRI · Trintellix · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VIATORR Endoprosthesis · VNS Therapy SenTiva Model 1000 Generator · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAKIX · Wakix · XCOPRI · XYWAV · Xadago · ZEMBRACE SYMTOUCH · ZEPOSIA · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Opticians within 10 mi
47
Per 100K population
17.8
County median income
$85,634
Nearest hospital
UPMC CARLISLE
4.7 mi
4.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Ismail is a mixed practice specialist, with above-average Medicare volume (top 2% in PA), with low-engagement industry engagement in the top 14% of PA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Ismail experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Ismail performed 10,301 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ismail receive payments from pharmaceutical companies?
Yes. Dr. Ismail received a total of $12,666 from 78 companies across 672 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ismail's costs compare to other opticians in Carlisle?
Dr. Ismail's average Medicare payment per service is $19. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ismail) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Carlisle
Browse opticians in Carlisle ranked by procedure volume and transparency data.
Highest volume
Top Opticians in PA
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in PA
Which PA opticians receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology